Narcobarbital
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
5-(2-bromoprop-2-en-1-yl)-5-isopropyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione | |
| Identifiers | |
| CAS Number |
125-55-3 |
| ATC code | N01AG01 (WHO) |
| PubChem | CID 18735 |
| ChemSpider |
17691 |
| KEGG |
C17722 |
| ChEMBL |
CHEMBL92963 |
| Chemical data | |
| Formula | C11H15BrN2O3 |
| Molar mass | 303.152 g/mol |
| |
| |
| (verify) | |
Narcobarbital (Pronarcon) is a barbiturate derivative developed by Riedel de Hean in the 1930s.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.
References
- ↑ US Patent 2080071
| ||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
